Asia-Pacific COVID-19 Diagnostics Market Size, Share, Analysis, Industry Report and Forecast 2020-2026

Asia-Pacific COVID-19 diagnostics market will see a declined growth of 22.2% during the forecast period. Asia-Pacific COVID-19 diagnostics market has been growing at a rapid pace owing to significantly growing screening tests in emerging economies such as India, China, Japan, and the Rest of the Asia-Pacific countries.

Request a Free Sample of our Asia-Pacific COVID-19 Diagnostics Market: https://www.omrglobal.com/request-sample/asia-pacific-covid-19-diagnostics-market

• On April 19, 2020, the Government of Japan passed an emergency budget worth around $240 billion, comprising cash handouts for every resident, to fight with the economic devastation formed by the COVID-19 outbreak. The budget also includes money to boost the production of masks for medical workers, improve COVID-19 testing capacity, and support the acceleration of drug and vaccine development.
• As of April 30, 2020, according to the International Monetary Fund (IMF), an estimated $367 billion in fiscal measures or financing have been announced to fight the virus. The package includes increased epidemic prevention spending, production of medical equipment, moving up unemployment payments, and social security tax relief.
• On March 26, 2020, the Government of India has announced a $22.6 billion stimulus plan to directly aid poorer communities affected by the COVID-19 lockdown. On 13th May 2020, the government of India announced a new stimulus package called the "Self-Reliant India," program accounted for a grant of $266 billion in the country.

A full Report of Asia-Pacific COVID-19 Diagnostics Market is Available at: https://www.omrglobal.com/industry-reports/asia-pacific-covid-19-diagnostics-market

Key questions addressed by the report

• What is the market growth rate during the forecast period?
• Which segment/region dominates the market in the base year?
• Which segment/region will project the fastest growth in the market during the forecast period?
• How COVID-19 will impact the market growth in 2020 and coming years?
o Recovery Timeline
o Deviation from pre-COVID-19
o Most affected region/segment
o Recommendations
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Asia-Pacific COVID-19 Diagnostics Market – Segmentation

By Type

• Instruments
• Reagents & Kits
• Laboratory Testing Services

By Technology Type

• PCR Test
• Antigen Test
o Chromatographic Immunoassay
o Fluorescent Immunoassay
o Chemiluminescent Immunoassay
• Serology Test
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Neutralization
o Chemiluminescent Immunoassay
• Rapid/ PoC Test

By Sample Type

• Oropharyngeal & Nasopharyngeal Swabs
• Blood
• Urine
• Saliva
• Others (Sperm)

By End-Users

• Laboratories
• Hospitals
• Diagnostic Centers & Clinics
• Research Institutes

Asia-Pacific COVID-19 Diagnostics Market – Segmentation by Geography

• China
• India
• Japan
• Rest of Asia-Pacific

Company Profiles

• ADT BiotechSdnBhd
• BGI Group
• CPC Diagnostics Pvt. Ltd.
• Guangzhou Wondfo Biotech Co., Ltd.
• J Mitra & Co. Pvt Ltd.
• Mylab Discovery Solutions Pvt Ltd.
• Sansure Biotech Inc.
• Seegene Inc.
• Sysmex Corp.
• Veredus Laboratories Pte Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-covid-19-diagnostics-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.